ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) (GEM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01301443
Recruitment Status : Completed
First Posted : February 23, 2011
Last Update Posted : April 5, 2017
Sponsor:
Information provided by (Responsible Party):
Oxford BioMedica